| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 09/25/1997 | WO1997034921A1 Conjugated mucin peptide vaccines |
| 09/25/1997 | WO1997034918A1 Chromatographic process for obtaining very pure cyclosporin a and related cyclosporins |
| 09/25/1997 | WO1997034621A1 Hla-a2.1 binding peptides and their uses |
| 09/25/1997 | WO1997030024A3 Lipids and their use, for example, in liposomes |
| 09/25/1997 | WO1997027220A3 Substrates and inhibitors for cysteine protease ich-1 |
| 09/25/1997 | WO1997026277A3 Morphogen analogs and methods for producing them |
| 09/25/1997 | DE19611094A1 Chromatographisches Verfahren zur Gewinnung von hochgereinigtem Cyclosporin A und verwandten Cyclosporinen Chromatographic method for the recovery of highly purified cyclosporin A and related cyclosporins |
| 09/25/1997 | CA2249395A1 Conjugated mucin peptide vaccines |
| 09/24/1997 | EP0796565A1 Orally administrable product for animal treatment |
| 09/24/1997 | EP0796335A1 Production of peptides using recombinant fusion protein constructs |
| 09/24/1997 | EP0796278A1 Disulphide-cyclo- h-cys-glu-gln-tyr-cys-oh], and its use in blood-clotting disorders |
| 09/24/1997 | EP0796272A1 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 09/24/1997 | EP0606463A4 Neuromedin b receptor antagonists. |
| 09/23/1997 | US5670619 Bradykinin-antagonists for the treatment of acute pancreatitis |
| 09/23/1997 | US5670483 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 09/23/1997 | US5670482 Neuropeptide Y antagonists |
| 09/23/1997 | US5670479 α-ketoamide derivatives as inhibitors of thrombosis |
| 09/23/1997 | US5670310 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection |
| 09/23/1997 | US5670155 Confomationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| 09/23/1997 | US5670133 Chemotactic peptide containing labeled metal binding ions |
| 09/18/1997 | WO1997034146A1 Inhibiting protein interactions |
| 09/18/1997 | WO1997033910A1 Immunomodulatory peptides of vespid antigen 5 |
| 09/18/1997 | WO1997033603A1 Novel peptides which inhibit complement activation |
| 09/18/1997 | WO1997025343A3 Antithrombotic agents and methods of use |
| 09/18/1997 | CA2248998A1 Inhibiting protein interactions |
| 09/18/1997 | CA2248537A1 Immunomodulatory peptides of vespid antigen 5 |
| 09/17/1997 | EP0794961A2 Lhrh antagonist peptides |
| 09/17/1997 | EP0794959A1 Amino acids for making betides and methods of screening and making betide libraries |
| 09/17/1997 | EP0634937B1 Vaccines containing non-ionic surfactant vesicles |
| 09/17/1997 | CN1159830A Immunomodulators |
| 09/17/1997 | CN1159811A Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 09/17/1997 | CN1159758A Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 09/17/1997 | CN1035873C Preparation of amides and peptides |
| 09/16/1997 | US5668254 Bioactive, oxidation resistance |
| 09/16/1997 | US5668111 Sustained-release preparation |
| 09/16/1997 | US5668110 Peptides and compounds that bind to the IL-5 receptor |
| 09/16/1997 | US5668105 Aza cyclohexapeptide compounds |
| 09/16/1997 | US5667991 Recombinant mersacidin and a method for production |
| 09/16/1997 | US5667988 Gene expression and genes with antibodies and antigens |
| 09/16/1997 | CA1339466C Vaccine |
| 09/12/1997 | WO1997032994A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 09/12/1997 | WO1997032975A1 Process for the deacylation of cyclic lipopeptides |
| 09/12/1997 | WO1997032900A1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 09/12/1997 | WO1997032899A1 Receptor derived peptides involved in modulation of response to ligand binding |
| 09/12/1997 | WO1997032895A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/12/1997 | WO1997032598A2 Vaccines |
| 09/12/1997 | WO1997032594A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 09/12/1997 | WO1997012636A3 Bifunctional sulphide-containing sulphonamide s2ny-type chelate-forming agents for radioisotopes |
| 09/12/1997 | WO1997008199A3 Antimicrobial cationic peptides and methods of screening for the same |
| 09/12/1997 | CA2248630A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 09/12/1997 | CA2248255A1 Receptor derived peptides involved in modulation of response to ligand binding |
| 09/12/1997 | CA2244733A1 Method for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cells |
| 09/10/1997 | EP0793966A1 Cyclosporin-containing topical pharmaceutical composition |
| 09/10/1997 | EP0793721A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 09/10/1997 | EP0793675A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 09/10/1997 | EP0669001B1 Determination of peptide motifs on mhc molecules |
| 09/10/1997 | EP0568698B1 Process for producing cyclosporin a and/or c |
| 09/10/1997 | EP0553357B1 Novel prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors |
| 09/10/1997 | EP0466833B1 Protease inhibitor |
| 09/10/1997 | CN1159197A Purified form of streptogramines, preparation thereof and pharmacueitcal compositions containing it |
| 09/10/1997 | CN1158856A Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/09/1997 | US5665703 GE3 compound |
| 09/09/1997 | US5665552 Antibodies to plasmodium falciparum |
| 09/09/1997 | US5665357 Antibodies recognizing tumor associated antigen CA 55.1 |
| 09/04/1997 | WO1997031948A1 Peptide immunogens for vaccination against and treatment of allergy |
| 09/04/1997 | WO1997031941A2 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | WO1997031657A2 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors |
| 09/04/1997 | CA2247802A1 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | CA2247430A1 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors |
| 09/03/1997 | EP0792886A1 Novel peptide and therapeutic agent |
| 09/03/1997 | EP0792373A1 A scintillation proximity assay for n-acetylgalactosaminyltransferase activity |
| 09/03/1997 | EP0792289A1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 09/03/1997 | EP0792158A1 Use of angiotensin ii fragments and analogs thereof in tissue repair |
| 09/03/1997 | CN1158622A Polypeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone |
| 09/03/1997 | CN1158621A Complexes for use in the diagnosis of vascular diseases |
| 09/03/1997 | CN1158619A Delivery of nucleic acids |
| 09/02/1997 | US5663303 Antibodies specific for retinoic acid receptor-γ |
| 09/02/1997 | US5663297 Antithrombic peptides |
| 09/02/1997 | US5663295 Analgesic, antidiarrhea |
| 09/02/1997 | US5663294 Anticoagulant oligopeptides or polypeptides |
| 09/02/1997 | US5663149 Anticarcinogenic agents related to dolastatin |
| 09/02/1997 | US5663146 Administering a synergistic combination to animals, including humans |
| 09/02/1997 | US5663144 Compounds that bind to p185 and methods of using the same |
| 08/28/1997 | WO1997031113A1 Cell-based assay |
| 08/28/1997 | WO1997031023A1 Peptide derivatives |
| 08/28/1997 | WO1997031017A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 08/28/1997 | WO1997030975A2 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 08/28/1997 | WO1997019953A3 New lh-rh antagonists with improved effectiveness |
| 08/28/1997 | WO1997010853A3 N2s2-type bi-functional nicotinamide chelating agents for radioactive isotopes |
| 08/28/1997 | CA2246300A1 Cell-based assay |
| 08/28/1997 | CA2242809A1 Peptide derivatives |
| 08/27/1997 | EP0791012A1 Peptides exhibiting oxytocin antagonistic activity |
| 08/27/1997 | EP0790831A1 Method for reducing the severity of gastro-intestinal damage |
| 08/27/1997 | EP0790830A1 Trophinin and trophinin-assisting proteins |
| 08/27/1997 | EP0400065B1 Lhrh analog |
| 08/26/1997 | US5661127 Peptide compositions with growth factor-like activity |
| 08/26/1997 | CA1339387C Magainins-synthetic antimicrobial compounds |
| 08/26/1997 | CA1339365C Oligopeptides and intermediates and processes for their manufacture |
| 08/21/1997 | WO1997030080A1 Macrocyclic peptides useful in the treatment of thrombin related disorders |
| 08/21/1997 | WO1997030074A1 Isolation and use of sh3 binding peptides |